China biotech Junshi Biosciences seeks up to $414mln in Hong Kong IPO
By Julia Fioretti HONG KONG: Chinese biotech company Shanghai Junshi Biosciences is seeking up to $414 million in a Hong Kong initial public offering (IPO), making it the latest company…
FDA clears Pear Therapeutics’ mobile app to help treat opioid abuse
The U.S. Food and Drug Administration on Monday cleared Pear Therapeutics’ mobile application to help increase retention of patients undergoing outpatient treatment for opioid abuse. The reSET-O app is a…
Supernus Pharma’s ADHD treatment meets main goal in two studies
Supernus Pharmaceuticals Inc on Thursday said its experimental treatment for attention deficit hyperactivity disorder met the main goal of reducing symptoms in affected children from six to 11 years of…
In pharmaceutical tubing, the chemical property defines the glass : Georg Sparschuh
Shahid Akhter, editor, ET Healthworld spoke to Georg Sparschuh, Managing Director, Schott Glass India Pvt., Jambusar, Gujarat, to know more about the quality of glass used in pharmaceutical packaging. SCHOTT…
HUL unlikely to become the largest food company: Experts
NEW DELHI: Hindustan Unilever, the country’s largest consumer products company, is unlikely to become the largest food company despite its acquisition of GSK Consumer business including Horlicks, because it still…
Maha FDA Yet To Set Up NPPA Cell To Detect Ceiling Price Violation
The Maharashtra Food and Drug Administration (FDA) is yet to set up an NPPA cell to deal with the drug price ceiling violation at its headquarters in Mumbai for want…
USFDA recommends regulatory action after Jubilant Life’s Roorkee plant inspection
New Delhi: The US health regulator has recommended a regulatory or administrative action after the inspection of Roorkee manufacturing facility of drug firm Jubilant Life Sciences, according to a regulatory…
AstraZeneca’s Imfinzi fails to meet main goals in head and neck cancer study
AstraZeneca Plc’s immunotherapy treatment Imfinzi did not meet the main goals in a late-stage study for advanced head and neck cancer, the London-listed drugmaker said on Friday. The study, known…
Moderna, largest biotech to go public, fails to impress in market debut
Moderna Inc’s shares fell as much as 6 percent in an upsized market debut on Friday, taking a hit from a broader selloff in the U.S. markets spurred by investors…
VAT scam: Pharmaceutical firm vice-chairman in judicial custody
CHANDIGARH: The district court remanded N R Munjal, vice-chairman, Ind-Swift pharma firm, to 14-day judicial custody. Munjal was arrested for his alleged involvement in the VAT evasion scam that rocked…
